EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation.
Acquired by Curaleaf
EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation, extraction, and production. It has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis
but also as a European leader in the production and supply of medical cannabis, hemp, and other derivatives products.
It was founded in 2018 and is headquartered in London, England.